sarcoglycan抗体と関連製品
Santa Cruz Biotechnology社は、様々な研究用途のためにサルコグリカンモノクローナル抗体の包括的なコレクションを提供しています。サルコグリカンモノクローナル抗体は、ウェスタンブロッティング（WB）、免疫沈降（IP）、免疫蛍光（IF）、パラフィン包埋切片を用いた免疫組織化学（IHCP）、フローサイトメトリー（FCM）、酵素結合免疫吸着測定法（ELISA）に適しています。サルコグリカンはジストロフィン-糖タンパク質複合体の不可欠な成分であり、筋細胞の完全性と機能の維持に重要な役割を果たしている。サルコグリカン遺伝子の変異は、いくつかの型の筋ジストロフィーと関連しており、筋生物学および疾患におけるその重要性が強調されている。サルコグリカンの機能と制御を理解することは、筋関連疾患の治療戦略を前進させるために不可欠である。サルコグリカンモノクローナル抗体は、正常筋組織と疾患筋組織の両方におけるタンパク質の発現パターンと相互作用の詳細な解析を可能にする。研究者は、筋の発達や再生に関与する細胞シグナル伝達経路や分子メカニズムを効果的に調べることができる。Santa Cruz Biotechnologyのモノクローナル抗体の卓越した特異性と信頼性は、筋生物学研究の進展と筋疾患の潜在的治療法の開発において世界中の科学者をサポートしています。
sarcoglycan 抗体
| Empty Table Header | 製品名 | CATALOG # | アイソタイプ | エピトープ | アプリケーション | Species | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|---|
α-sarcoglycan 抗体 (D-7) | sc-271321 | mouse IgG1 κ | 24-105 (h) | WB, IP, IF, ELISA | m, r, h | 3 | ||
α-sarcoglycan 抗体 (C-12) | sc-515255 | mouse IgG2a κ | 363-382 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
α-sarcoglycan 抗体 (F-7) | sc-390647 | mouse IgG2a λ | 43-68 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 4 | ||
α-sarcoglycan 抗体 (G-11) | sc-515299 | mouse IgG2b κ | 365-382 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
β-sarcoglycan 抗体 (RO-17) | sc-100956 | mouse IgG2a κ | 87-197 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
β-sarcoglycan 抗体 (F-6) | sc-393679 | mouse IgG1 κ | 221-318 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
δ-sarcoglycan 抗体 (B-5) | sc-515755 | mouse IgG1 κ | 206-260 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
δ-sarcoglycan 抗体 (3G10) | sc-517013 | mouse IgG1 κ | 114-189 (h) | WB, IP, ELISA | h | new | ||
γ-sarcoglycan 抗体 (E-8) | sc-515628 | mouse IgG1 κ | 221-246 (h) | WB, IP, IF, ELISA | h | 1 |
sarcoglycan CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
α-sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-403837 | h | Gene Knockout | GFP | 0 | ||
α-sarcoglycan Double Nickaseプラスミド (h) | sc-403837-NIC | h | Gene Knockout | Puromycin | 0 | ||
α-sarcoglycan Double Nickaseプラスミド (h2) | sc-403837-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
α-sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-422904 | m | Gene Knockout | GFP | 0 | ||
α-sarcoglycan HDRプラスミド (m2) | sc-422904-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
α-sarcoglycan Double Nickaseプラスミド (m) | sc-422904-NIC | m | Gene Knockout | Puromycin | 0 | ||
α-sarcoglycan Double Nickaseプラスミド (m2) | sc-422904-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
β-sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-404718 | h | Gene Knockout | GFP | 0 | ||
β-sarcoglycan HDRプラスミド (h) | sc-404718-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
β-sarcoglycan Double Nickaseプラスミド (h) | sc-404718-NIC | h | Gene Knockout | Puromycin | 0 | ||
β-sarcoglycan Double Nickaseプラスミド (h2) | sc-404718-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
β-sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-423958 | m | Gene Knockout | GFP | 0 | ||
β-sarcoglycan HDRプラスミド (m) | sc-423958-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
β-sarcoglycan Double Nickaseプラスミド (m) | sc-423958-NIC | m | Gene Knockout | Puromycin | 0 | ||
β-sarcoglycan Double Nickaseプラスミド (m2) | sc-423958-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
δ-sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-404912 | h | Gene Knockout | GFP | 0 | ||
δ-sarcoglycan HDRプラスミド (h) | sc-404912-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
δ-sarcoglycan Double Nickaseプラスミド (h) | sc-404912-NIC | h | Gene Knockout | Puromycin | 0 | ||
δ-sarcoglycan Double Nickaseプラスミド (h2) | sc-404912-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
δ-sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-423959 | m | Gene Knockout | GFP | 0 | ||
δ-sarcoglycan HDRプラスミド (m) | sc-423959-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
δ-sarcoglycan Double Nickaseプラスミド (m) | sc-423959-NIC | m | Gene Knockout | Puromycin | 0 | ||
δ-sarcoglycan Double Nickaseプラスミド (m2) | sc-423959-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ε-sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-407746 | h | Gene Knockout | GFP | 0 | ||
ε-sarcoglycan HDRプラスミド (h) | sc-407746-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ε-sarcoglycan Double Nickaseプラスミド (h) | sc-407746-NIC | h | Gene Knockout | Puromycin | 0 | ||
ε-sarcoglycan Double Nickaseプラスミド (h2) | sc-407746-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ε-sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-422905 | m | Gene Knockout | GFP | 0 | ||
ε-sarcoglycan HDRプラスミド (m) | sc-422905-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ε-sarcoglycan Double Nickaseプラスミド (m) | sc-422905-NIC | m | Gene Knockout | Puromycin | 0 | ||
ε-sarcoglycan Double Nickaseプラスミド (m2) | sc-422905-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
γ-sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-402275 | h | Gene Knockout | GFP | 0 | ||
γ-sarcoglycan HDRプラスミド (h) | sc-402275-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
γ-sarcoglycan Double Nickaseプラスミド (h) | sc-402275-NIC | h | Gene Knockout | Puromycin | 0 | ||
γ-sarcoglycan Double Nickaseプラスミド (h2) | sc-402275-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
γ-sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-423960 | m | Gene Knockout | GFP | 0 | ||
γ-sarcoglycan HDRプラスミド (m) | sc-423960-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
γ-sarcoglycan Double Nickaseプラスミド (m) | sc-423960-NIC | m | Gene Knockout | Puromycin | 0 | ||
γ-sarcoglycan Double Nickaseプラスミド (m2) | sc-423960-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ζ-Sarcoglycan CRISPR/Cas9 KOプラスミド (h) | sc-410304 | h | Gene Knockout | GFP | 0 | ||
ζ-Sarcoglycan HDRプラスミド (h) | sc-410304-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ζ-Sarcoglycan Double Nickaseプラスミド (h) | sc-410304-NIC | h | Gene Knockout | Puromycin | 0 | ||
ζ-Sarcoglycan Double Nickaseプラスミド (h2) | sc-410304-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ζ-Sarcoglycan CRISPR/Cas9 KOプラスミド (m) | sc-434068 | m | Gene Knockout | GFP | 0 | ||
ζ-Sarcoglycan HDRプラスミド (m) | sc-434068-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ζ-Sarcoglycan Double Nickaseプラスミド (m) | sc-434068-NIC | m | Gene Knockout | Puromycin | 0 | ||
ζ-Sarcoglycan Double Nickaseプラスミド (m2) | sc-434068-NIC-2 | m | Gene Knockout | Puromycin | 0 |
sarcoglycan CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
α-sarcoglycan CRISPR Activationプラスミド (h) | sc-403837-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan CRISPR Activationプラスミド (h2) | sc-403837-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan Lentiviral Activation Particles (h) | sc-403837-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan Lentiviral Activation Particles (h2) | sc-403837-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan CRISPR Activationプラスミド (m) | sc-422904-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan CRISPR Activationプラスミド (m2) | sc-422904-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan Lentiviral Activation Particles (m) | sc-422904-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
α-sarcoglycan Lentiviral Activation Particles (m2) | sc-422904-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan CRISPR Activationプラスミド (h) | sc-404718-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan CRISPR Activationプラスミド (h2) | sc-404718-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan Lentiviral Activation Particles (h) | sc-404718-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan Lentiviral Activation Particles (h2) | sc-404718-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan CRISPR Activationプラスミド (m) | sc-423958-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan CRISPR Activationプラスミド (m2) | sc-423958-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan Lentiviral Activation Particles (m) | sc-423958-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
β-sarcoglycan Lentiviral Activation Particles (m2) | sc-423958-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan CRISPR Activationプラスミド (h) | sc-404912-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan CRISPR Activationプラスミド (h2) | sc-404912-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan Lentiviral Activation Particles (h) | sc-404912-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan Lentiviral Activation Particles (h2) | sc-404912-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan CRISPR Activationプラスミド (m) | sc-423959-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan CRISPR Activationプラスミド (m2) | sc-423959-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan Lentiviral Activation Particles (m) | sc-423959-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
δ-sarcoglycan Lentiviral Activation Particles (m2) | sc-423959-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan CRISPR Activationプラスミド (h) | sc-407746-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan CRISPR Activationプラスミド (h2) | sc-407746-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan Lentiviral Activation Particles (h) | sc-407746-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan Lentiviral Activation Particles (h2) | sc-407746-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan CRISPR Activationプラスミド (m) | sc-422905-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan CRISPR Activationプラスミド (m2) | sc-422905-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan Lentiviral Activation Particles (m) | sc-422905-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ε-sarcoglycan Lentiviral Activation Particles (m2) | sc-422905-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan CRISPR Activationプラスミド (h) | sc-402275-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan CRISPR Activationプラスミド (h2) | sc-402275-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan Lentiviral Activation Particles (h) | sc-402275-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan Lentiviral Activation Particles (h2) | sc-402275-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan CRISPR Activationプラスミド (m) | sc-423960-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan CRISPR Activationプラスミド (m2) | sc-423960-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan Lentiviral Activation Particles (m) | sc-423960-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
γ-sarcoglycan Lentiviral Activation Particles (m2) | sc-423960-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan CRISPR Activationプラスミド (h) | sc-410304-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan CRISPR Activationプラスミド (h2) | sc-410304-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan Lentiviral Activation Particles (h) | sc-410304-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan Lentiviral Activation Particles (h2) | sc-410304-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan CRISPR Activationプラスミド (m) | sc-434068-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan CRISPR Activationプラスミド (m2) | sc-434068-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan Lentiviral Activation Particles (m) | sc-434068-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ζ-Sarcoglycan Lentiviral Activation Particles (m2) | sc-434068-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
sarcoglycan siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
α-sarcoglycan siRNA (h) | sc-43416 | h | Gene Silencing | N/A | 0 | ||
α-sarcoglycan shRNA プラスミド (h) | sc-43416-SH | h | Gene Silencing | Puromycin | 0 | ||
α-sarcoglycan shRNA (h) レンチウイルス粒子 | sc-43416-V | h | Gene Silencing | Puromycin | 0 | ||
α-sarcoglycan siRNA (m) | sc-43417 | m | Gene Silencing | N/A | 0 | ||
α-sarcoglycan shRNA プラスミド (m) | sc-43417-SH | m | Gene Silencing | Puromycin | 0 | ||
α-sarcoglycan shRNA (m) レンチウイルス粒子 | sc-43417-V | m | Gene Silencing | Puromycin | 0 | ||
β-sarcoglycan siRNA (h) | sc-43418 | h | Gene Silencing | N/A | 0 | ||
β-sarcoglycan shRNA プラスミド (h) | sc-43418-SH | h | Gene Silencing | Puromycin | 0 | ||
β-sarcoglycan shRNA (h) レンチウイルス粒子 | sc-43418-V | h | Gene Silencing | Puromycin | 0 | ||
β-sarcoglycan siRNA (m) | sc-43419 | m | Gene Silencing | N/A | 0 | ||
β-sarcoglycan shRNA プラスミド (m) | sc-43419-SH | m | Gene Silencing | Puromycin | 0 | ||
β-sarcoglycan shRNA (m) レンチウイルス粒子 | sc-43419-V | m | Gene Silencing | Puromycin | 0 | ||
δ-sarcoglycan siRNA (h) | sc-43420 | h | Gene Silencing | N/A | 0 | ||
δ-sarcoglycan shRNA プラスミド (h) | sc-43420-SH | h | Gene Silencing | Puromycin | 0 | ||
δ-sarcoglycan shRNA (h) レンチウイルス粒子 | sc-43420-V | h | Gene Silencing | Puromycin | 0 | ||
δ-sarcoglycan siRNA (m) | sc-43421 | m | Gene Silencing | N/A | 0 | ||
δ-sarcoglycan shRNA プラスミド (m) | sc-43421-SH | m | Gene Silencing | Puromycin | 0 | ||
δ-sarcoglycan shRNA (m) レンチウイルス粒子 | sc-43421-V | m | Gene Silencing | Puromycin | 0 | ||
ε-sarcoglycan siRNA (h) | sc-43422 | h | Gene Silencing | N/A | 0 | ||
ε-sarcoglycan shRNA プラスミド (h) | sc-43422-SH | h | Gene Silencing | Puromycin | 0 | ||
ε-sarcoglycan shRNA (h) レンチウイルス粒子 | sc-43422-V | h | Gene Silencing | Puromycin | 0 | ||
ε-sarcoglycan siRNA (m) | sc-43423 | m | Gene Silencing | N/A | 0 | ||
ε-sarcoglycan shRNA プラスミド (m) | sc-43423-SH | m | Gene Silencing | Puromycin | 0 | ||
ε-sarcoglycan shRNA (m) レンチウイルス粒子 | sc-43423-V | m | Gene Silencing | Puromycin | 0 | ||
γ-sarcoglycan siRNA (h) | sc-43424 | h | Gene Silencing | N/A | 0 | ||
γ-sarcoglycan shRNA プラスミド (h) | sc-43424-SH | h | Gene Silencing | Puromycin | 0 | ||
γ-sarcoglycan shRNA (h) レンチウイルス粒子 | sc-43424-V | h | Gene Silencing | Puromycin | 0 | ||
γ-sarcoglycan siRNA (m) | sc-43425 | m | Gene Silencing | N/A | 0 | ||
γ-sarcoglycan shRNA プラスミド (m) | sc-43425-SH | m | Gene Silencing | Puromycin | 0 | ||
γ-sarcoglycan shRNA (m) レンチウイルス粒子 | sc-43425-V | m | Gene Silencing | Puromycin | 0 | ||
ζ-Sarcoglycan siRNA (h) | sc-77454 | h | Gene Silencing | N/A | 0 | ||
ζ-Sarcoglycan shRNA プラスミド (h) | sc-77454-SH | h | Gene Silencing | Puromycin | 0 | ||
ζ-Sarcoglycan shRNA (h) レンチウイルス粒子 | sc-77454-V | h | Gene Silencing | Puromycin | 0 | ||
ζ-Sarcoglycan siRNA (m) | sc-155981 | m | Gene Silencing | N/A | 0 | ||
ζ-Sarcoglycan shRNA プラスミド (m) | sc-155981-SH | m | Gene Silencing | Puromycin | 0 | ||
ζ-Sarcoglycan shRNA (m) レンチウイルス粒子 | sc-155981-V | m | Gene Silencing | Puromycin | 0 |